TMDX

NASDAQ HEALTHCARE

TransMedics Group Inc

$72.06

-$0.34 (-0.47%)

Live quote

52w: $60.11 – $156.00

Loading chart…

P/E Ratio13.19

P/B Ratio4.85

EV/EBITDA—

Debt/Equity—

ROE36.73%

ROIC—

Revenue Growth37.13%

Gross Margin59.92%

TransMedics Group, Inc., a commercial-stage medical technology company, is dedicated to transforming organ transplant therapy for patients with end-stage organ failure in the United States and internationally. The company is headquartered in Andover, Massachusetts.

Own TMDX? Track it here.

Create a free account to add TMDX to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account